Su XP. et al.
NSD1 inactivation and SETD2 mutation drive a convergence toward loss of function of H3K36 writers in Clear Cell Renal Cell Carcinomas.
Cancer Res. (2017) Sept. 77 (18): 4835-4845
doi: 10.1158/0008-5472.CAN-17-0143
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Su XP. et al.
NSD1 inactivation and SETD2 mutation drive a convergence toward loss of function of H3K36 writers in Clear Cell Renal Cell Carcinomas.
Cancer Res. (2017) Sept. 77 (18): 4835-4845
doi: 10.1158/0008-5472.CAN-17-0143